WomanCare Global Adds Conception Kit® to Product Portfolio

- Helps Women Increase Their Chances of Conceiving

LONDON, April 26, 2012 /PRNewswire/ -- WomanCare Global announced the addition of the Conception Kit® to their comprehensive portfolio of high-quality, safe and affordable reproductive healthcare products. The Conception Kit® represents the first fertility product in the portfolio and will be available in the UK and other countries (excluding U.S. and Canada).

(Logo: http://photos.prnewswire.com/prnh/20101018/DC83896LOGO)

The Conception Kit® is a proven resource for couples trying to conceive a child. The Conception Kit® has demonstrated a success rate of 16-25% and includes an ovulation predictor, pregnancy tests, and an innovative Conception Cap®. Studies show that 1 in 4 couples have been proven to become pregnant using the Conception Cap® technique.(1, 2)

Saundra Pelletier, Chief Executive Officer of WomanCare Global stated that, "Empowering women to manage the full range of their reproductive health and family planning needs is at the heart of what we do.  With the addition of the Conception Kit®, we now offer women safe, high-quality and affordable products across the entire reproductive health continuum."

"The Conception Kit® benefits couples who want to, but haven't yet been able to conceive," said Dr. Matthew Reeves, WomanCare Global's Chief Medical Officer and Board Certified OB/GYN. "The Conception Kit® provides a cost-effective, at home option that can be used prior to more expensive and invasive fertility procedures."

According to Dr. Reeves, the Conception Kit® is ideal for women who meet any of these criteria:

• Unable to conceive after multiple attempts for a period of 6 to 18 months
• Open to a less expensive, at home assisted conception method
• Currently on, or waiting to be placed on, the NHS IVF list in the UK.

The Conception Kit® is available online, without a prescription, at a low introductory price.  For more information, or to place an order, visit http://www.conceptionkit.co.uk.  

About WomanCare Global:
WomanCare Global improves the lives of women, their families, and communities, by enabling access to quality, affordable birth control and reproductive healthcare products. We believe that when women can choose whether and when they'll have children, they can be at their best.  The result is greater personal empowerment, flourishing families, prosperous communities, and for all of us, a better world.  While serving women is the passion that drives what we do, it's our business intelligence that makes our work possible.  We strategically redirect revenue from developed countries to underserved markets.  In this way, we eliminate economic and geographic barriers and increase our impact, reaching women no matter where they live, in more than 100 countries worldwide. WomanCare Global was founded by Ipas in 2009 and operates independently as a UK Registered Charity (No.1138896). For more information, please visit womancareglobal.org.

About Conceivex:
Conceivex, Inc. is a privately owned reproductive healthcare company headquartered in Western Michigan. The company developed and produced the Conception Cap® and the Conception Kit®. The Conception Kit® is FDA & CE approved.

(1) Coulson C, et al. Human Reproduction 1996; 11:84-87
(2) Data on file